Clinical Trial Update: Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating an oral formula to prevent side effects from anti-cancer therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Nestlé oral formula for prevention of anti-cancer therapy side effects

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Digestive Cancers | Phase 3 | Status: COMPLETED